Sanofi Us Services Inc - Cambridge, Massachusetts 02142

Sanofi Us Services Inc is categorized under in Cambridge, MA .

Business Name: Sanofi Us Services Inc
Address: 300 3rd St, Cambridge, Massachusetts 02142
Phone Number: (617) 665-4501
Website Address: sanofi.us
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: Il Pharma Inc - Cambridge, MA 02142
Millennium Pharmaceuticals - Cambridge, MA 02142
Newco Ls13 - Cambridge, MA 02142
Shape Pharmaceuticals Inc - Cambridge, MA 02142
Verastem Inc - Cambridge, MA 02142
Targanta Therapeutics Corporation - Cambridge, MA 02142
Edimer Pharmaceuticals - Cambridge, MA 02142
Eleven Biotherapeutics - Cambridge, MA 02142
Constellation Pharmaceuticals - Cambridge, MA 02142
Aegerion Pharmaceuticals Inc - Cambridge, MA 02142
Via Cord LLC - Cambridge, MA 02142
Akanas Therapeutics Inc - Cambridge, MA 02142
Lipomed Inc - Cambridge, MA 02142
Ironwood Pharmaceuticals Inc - Cambridge, MA 02142
Momenta Pharmaceuticals Inc - Cambridge, MA 02142
Alnylam Pharmaceuticals Inc - Cambridge, MA 02142
Sarepta Therapeutics Inc - Cambridge, MA 02142
Zalicus Inc - Cambridge, MA 02142
Clarus Ventures LLC - Cambridge, MA 02142
Gloucester Pharmaceuticals Inc - Cambridge, MA 02142

The company Sanofi Us Services Inc provides BOTH services in the form of from its branch in Massachusetts. 1 to 4 employees work for Sanofi Us Services Inc, and the business now earns Unknown per annum.

Sanofi Us Services Inc was launched in 0 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Sanofi Us Services Inc, please call with the phone number (617) 665-4501 or visit its branch at 300 3rd St in Cambridge, Massachusetts 02142.

The location of the branch can also be found using the coordinates 42.365305,-71.082422. Read more details about this business on the webpage sanofi.us or follow the company’s social media accounts, on Twitter and on Facebook.